Clinical Trials Logo

Schizophrenia clinical trials

View clinical trials related to Schizophrenia.

Filter by:

NCT ID: NCT04436757 Recruiting - Schizophrenia Clinical Trials

Self and Body-esteem in Socio-professional Rehabilitation

IPS_FIRAH
Start date: June 22, 2020
Phase: N/A
Study type: Interventional

The body esteem influences the physical appearance, which can be a social brake. To enhance the socio-professional insertion of persons with severe mental disorders, the investigators developed a group program about self-presentation and body esteem. The study's objective is to understand the body esteem impact on socio-professional insertion, and how to improve that with a dedicated group program, for patients in a psychosocial rehabilitation center

NCT ID: NCT04432688 Completed - Schizophrenia Clinical Trials

The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients

Start date: December 1, 2020
Phase:
Study type: Observational [Patient Registry]

It's a prospective, non-interventional, observational Post-marketing Surveillance..

NCT ID: NCT04432116 Not yet recruiting - Schizophrenia Clinical Trials

Time and Virtual Reality in Schizophrenia and Bipolar Disorder

VirtualTimes
Start date: September 2020
Phase: N/A
Study type: Interventional

Patients with bipolar disorders report an acceleration or slowing of time flow, and patients with schizophrenic spectrum disorders a time fragmentation. These disorders would be linked to disorders of the sense of self. Assessing these time-related disorders could help to better predict psychotic conversion in vulnerable subjects. In this protocol, the investigators wish to develop playful methods for the evaluation of alterations in the passage of time, based on the use of virtual reality. The protocol will be tested in stabilized but chronic bipolar or schizophrenic patients, vs. healthy subjects matched on age, sex, and study level. The protocol will include two experimental sessions. It will begin with a waiting room-like session, at the end of which the subject will be asked to retrospectively estimate the time that will have passed. The games that will follow will all be based on the principle of temporal waiting. A first signal will indicate the start of the trial, and a target will be presented at varying times after this first signal. The later the target is presented, the more the subject expects and prepare for the target, and the faster he or she is. This time delay is measured by the subject's response (response time, error rate, eye fixation), but also by electrical signals measured by electroencephalography (EEG). The two experimental sessions will include several temporal manipulations during these tasks, intended to highlight alterations in the time flow in patients compared to controls. In one of the sessions, a starfield will be presented and the speed of the stars in the starfield will be manipulated, as a proxy for the speed of the environment. In one condition, the speed of the object will be average, and in the other the speed will be self-adjusted by the subject. In a control condition, the speed of the object will be zero. In the other experimental session, distractors will be presented during the waiting phase of the target. They will be presented either simultaneously or asynchronously. In one control condition the distractors will be absent. In both sessions it will be examined how the behavioral and EEG cues are affected by the manipulations. A double dissociation is expected, with greater disturbance in patients with bipolar disorder when standard movement is used, whereas patients with schizophrenia should be disturbed mainly when asynchronous distractors are presented.

NCT ID: NCT04430868 Not yet recruiting - Schizophrenia Clinical Trials

Lifestyle Redesign For Schizophrenia

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

This study aimed to investigate the effects of lifestyle redesign program plus treatment as usual versus treatment as usual on cognition, psychiatric symptoms, quality of life, and occupational engagement for schizophrenia.

NCT ID: NCT04430309 Recruiting - Schizophrenia Clinical Trials

Baduanjin on Patients With Schizophrenia

Start date: April 10, 2021
Phase: N/A
Study type: Interventional

As an ancient, popular Chinese exercise, Baduanjin is characterized by symmetrical posture, deep breathing and meditation and easy to learn. Previous studies showed immediate effect of Baduanjin on cognition in patients with schizophrenia.The purpose of this study is to investigate the immediate effect and chronic effect of Baduanjin exercise on physical fitness, cognition and daily functions in middle-aged and older adults with schizophrenia.

NCT ID: NCT04421456 Terminated - Schizophrenia Clinical Trials

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Start date: August 18, 2020
Phase: Phase 2
Study type: Interventional

This study will be conducted to evaluate the efficacy, safety, and tolerability of GWP42003-P versus placebo in participants with schizophrenia experiencing inadequate response to ongoing antipsychotic treatment.

NCT ID: NCT04418466 Completed - Schizophrenia Clinical Trials

Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant

DLP-114
Start date: April 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is an Open-Label Study in Stable Schizophrenia Patients to Evaluate the Safety, Tolerability, and Pharmacokinetics of Switching from Oral Risperidone to Risperidone Implant (DLP-114).

NCT ID: NCT04418011 Completed - Schizophrenia Clinical Trials

Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders

ModSoCCS
Start date: November 30, 2020
Phase: N/A
Study type: Interventional

In this study, the investigators will be examining the effects of repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) on social cognitive impairments in individuals with schizophrenia spectrum disorders. Participants will be chosen by chance to receive either active rTMS stimulation, active iTBS stimulation, sham rTMS, or sham iTBS. The investigators predict that active 10Hz and iTBS stimulation will improve social cognitive impairments compared to sham stimulation. We aim to identify which type of active stimulation is most effective at inducing changes social cognition brain circuitry and secondarily which type of active stimulation is best tolerated and most effective at inducing changes in social cognitive performance.

NCT ID: NCT04414930 Recruiting - Schizophrenia Clinical Trials

Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

Start date: November 9, 2020
Phase: Phase 2
Study type: Interventional

These studies look to conduct efficient pilot testing of a novel intervention strategy for chronic psychotic disorders - Pharmacologic Augmentation of Cognitive Therapy (PACT) - via an experimental medicine approach. Antipsychotics are the major therapeutic tool for chronic psychotic disorders, including schizophrenia, but do not significantly alter their course or real-life impact. Specific cognitive therapies achieve modest symptom reduction and improved function and cognition in psychosis patients, including "bottom-up" sensory-based targeted cognitive training (TCT). While benefits of TCT are evident at the group level, almost half of all patients demonstrate little or no cognitive gains after 30-40 hours (h) of TCT. For patients and clinicians, the costs and logistical complexities associated with these time- and resource-intensive interventions can be prohibitive. We propose and will test a novel "augmentation strategy" for using medications to specifically enhance the benefits of TCT in schizophrenia.

NCT ID: NCT04414215 Recruiting - Schizophrenia Clinical Trials

Cognitive Training for Emotion Regulation in Psychotic Disorders

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The current study examines the efficacy of a cognitive training intervention for improving emotion regulation in psychotic disorders. it is hypothesized that the cognitive training program will enhance prefrontal activation, leading to enhanced emotion regulation.